Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

Brian Stevens Biography and Net Worth

CAO of Baxter International

Brian Stevens is senior vice president, chief accounting officer and controller.

Stevens joined Baxter in 2018 from Groupon, Inc., where he most recently served as treasurer and chief accounting officer. He had served as Groupon’s chief accounting officer from 2012 to 2016 before assuming the treasurer role. Prior to joining Groupon, Stevens spent 16 years with KPMG LLP, most recently as a partner. He spent five years in KPMG’s Department of Professional Practice and was a practice fellow at the Financial Accounting Standards Board from 2006 to 2008.

Stevens received his bachelor of science degree in accountancy from the University of Illinois at Urbana-Champaign and is a licensed certified public accountant in Illinois and New York. He is a member of the American Institute of Certified Public Accountants and served on its Financial Reporting Executive Committee from 2013 to 2018.

What is Brian Stevens' net worth?: The estimated net worth of Brian Stevens is at least $6.50 million as of May 24th, 2018. Mr. Stevens owns 220,484 shares of Baxter International stock worth more than $6,504,278 as of December 22nd. This net worth approximation does not reflect any other assets that Mr. Stevens may own. Learn More about Brian Stevens' net worth.
How do I contact Brian Stevens?: The corporate mailing address for Mr. Stevens and other Baxter International executives is One Baxter Parkway DF2-1W, Deerfield IL, 60015. Baxter International can also be reached via phone at (224) 948-2000 and via email at [email protected]. Learn More on Brian Stevens' contact information.
Has Brian Stevens been buying or selling shares of Baxter International?: Brian Stevens has not been actively trading shares of Baxter International within the last three months. Most recently, Brian Stevens sold 2,500 shares of the business's stock in a transaction on Monday, February 28th. The shares were sold at an average price of $85.50, for a transaction totalling $213,750.00. Learn More on Brian Stevens' trading history.
Who are Baxter International's active insiders?: Baxter International's insider roster includes Giuseppe Accogli (SVP), John Forsyth (Director), Andrew Frye (SVP), James Gavin, III (Director), Jacqueline Kunzler (SVP), Sean Martin (SVP), Jeanne Mason (SVP), Brian Stevens (CAO), and Albert Stroucken (Director). Learn More on Baxter International's active insiders.

Brian Stevens Insider Trading History at Baxter International

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
2/28/2022	Sell	2,500	$85.50	$213,750.00

Brian Stevens Buying and Selling Activity at Baxter International

Baxter International Company Overview

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Today's Range

Now: $29.50

$29.17

$29.99

50 Day Range

MA: $33.70

$28.90

$36.91

2 Week Range

Now: $29.50

$28.62

$44.01

Volume

12,194,859 shs

Average Volume

4,174,975 shs

Market Capitalization

$15.06 billion

P/E Ratio

147.51

Dividend Yield

2.35%

Beta

0.58